Staff, Author at Becker’s Spine Review

10 trends in the bone grafts market

A new report from Persistence Market Research examines the bone grafts market and forecast through 2020.

When is MRI cost-effective for diagnosing meniscal tears? 5 key points

An article recently published in The American Journal of Sports Medicine analyzes the cost-effectiveness of meniscal tear diagnosis.

Healthcare spending slow-down: What it means for spine surgeons

It's no secret among spine surgeons that patients with high deductible insurance plans wait longer to have elective procedures. The problem is, more patients now have high deductible plans and the deductibles are much higher than they were a decade…

Medtronic-Covidien merger surges ahead: Chinese Ministry of Commerce clears proposed acquisition

Medtronic announced that the Chinese Ministry of Commerce has cleared its proposed acquisition of Covidien, according to a MarketWatch report.

Dr. Daniil Polishchuk joins OrthoNY

OrthoNY added Daniil Polishchuk, MD, to its physician team, according to a report by The Record Business.

Promising new drug allows paralyzed rats to regain some functions, study shows

The use of a new drug has allowed researchers to activate the paralyzed muscles of disabled rats, according to a report by The Independent.

How has the PPACA affected physician practices?

When asked how the Patient Protection and Affordable Care Act has affected their practices, physicians reported varying degrees of impact, according to Physicians Practice's 2014 Physician Compensation Survey:

Which law regulating the spine industry would spine surgeons change?

Three spine surgeons discuss which spine industry regulation they would change and why.

Spine surgeon leader to know: Dr. Daveed Frazier of New York City Spine

Daveed Frazier, MD, is an orthopedic spine surgeon providing care at New York City Spine and he is an assistant clinical professor of orthopedic surgery at Columbia University College of Physicians and Surgeons in New York. He is a member…

DePuy Synthes Spine receives FDA clearance for thoracic insufficiency syndrome rib devices

DePuy Synthes Spine announced its VEPTR/VEPTR II Vertical Expandable Prosthetic Titanium Rib Devices received 510(k) clearance from the U.S. Food and Drug Administration.